For the complete documentation index, see /llms.txt. The full corpus is available at /llms-full.txt. Most pages have a raw markdown variant; append .md to the URL or send Accept: text/markdown.

Blog  |  Product

Invert Launches Invert Assist

Invert Launches Invert Assist

Invert Assist: AI that speaks bioprocess—just like you do

Today, Invert launches Invert Assist, the first AI-powered analysis interface built for bioprocess. Using a simple chat interface, Invert Assist enables users to perform complex analysis that typically takes an expert team hours to code manually. With the freedom and flexibility of natural language, bioprocess scientists can turn days or even weeks of troubleshooting and optimization into a 5-minute conversation with their data.

Why now?

We produce roughly 180 zettabytes of data per year. To put that number in perspective, that exceeds the number of stars in the observable universe.

This massive amount of data means that most of it is under-utilized, and bioprocess data is no exception. The sheer volume of data produced means the vast majority of it is siloed and fragmented across upstream and downstream process, or between scales or sites of production. New modalities in cell and gene therapy and biologic manufacturing also contribute distinct challenges — tracking interdependent CQAs during viral vector production for gene therapies, or managing batch-to-batch variability for autologous cell therapies.

It’s clear that the biggest bottleneck in data isn’t producing it, but in being able to use it to close the gap between analysis and action. As articulated by Amgen CTO David Reese, “…those who figure out how to organize, harness, and analyze that data will separate the winners from the rest.”

Invert’s launching Invert Assist to create those winners.

What can Invert Assist do?

One of the main reasons why enterprise AI initiatives fail (source: MIT) is their inability to integrate deeply with domain-specific workflows. Invert Assist was designed, first and foremost, to fit seamlessly in bioprocess workflows.

__wf_reserved_inherit

Invert Assist is capable of performing both routine and more sophisticated analysis and modeling for bioprocess. It can detect trends and correlations between runs, conduct root cause analysis for deviations, construct predictive models and simulations of processes, and design future experiments based on current data.

If you’re interested in learning more about how Invert Assist could support your processes, request a demo here. Our team would be happy to put together a demo tailored to your specific use cases and needs.

Why Invert Assist?

Invert Assist only sources high quality, fully contextualized data from Invert’s core software. With a foundation of AI-ready data, users can be confident that results are grounded in their own bioprocess data from the bench to the manufacturing floor. We’ve also developed in-house evaluations tailored to bioprocess specifically to assess Invert Assist’s performance, ensuring that its answers are consistently accurate and reliable.

__wf_reserved_inherit

Unlike general-purpose large language models (LLMs) like ChatGPT, Invert Assist was also built to be compliant with biomanufacturing industry regulations and adhere to international best practices for AI use and development. Results from Invert Assist are fully traceable and audit-ready, which means users will not only be able to access the Python code used to execute analysis, they’ll be able to reproduce and verify them as well.

Just like Invert’s core software, Invert Assist is built with enterprise-grade infrastructure and adheres to strict industry standards for data privacy and security. Neither Invert nor our vendors ever train AI models on customer data.

Experience Invert Assist today

Seeing Invert Assist at work with your own process data is quick and easy. We’re introducing Invert Insight Sprint, a new POC offering that lets you get an immediate look into the power of AI-driven insights.

All we need is a few files of your historical data, like historical runs, deviations, or yield summaries. After signing an NDA, we’ll upload that data onto Invert, where it’ll automatically be made AI-ready. Then, you’ll be all set to start talking to your data:

  • Ask real questions (“What parameters led to low yield last quarter?”)
  • Uncover hidden trends (“Which sites show the most variability?”)
  • Quantify what could have been prevented (“If we’d had Invert, we could have saved 10 runs.”

In a few minutes, you’ll find out what you could’ve learned from your data if understanding it was as easy as a casual conversation with a colleague. Find out more about Insight Sprint by reaching out on our website.

Related Articles

Using in-line signals to predict viable-cell yield across iPSC-derived production lots
ProductJuly 21, 2026

Using in-line signals to predict viable-cell yield across iPSC-derived production lots

Across 16 simulated iPSC-derived production lots (same donor material, medium, and feed), viable-cell yield still swung from about 1.35 to 4.68 ×10⁹ cells per lot. Invert Assist read all 16 lots as one dataset, built an in-line soft sensor that predicts harvest viable-cell count to within about 5–10% from reactor signals alone, and traced the swing to a single controllable variable: differentiation-trigger timing. A lot switched 48 hours late overshot in expansion, then crashed, and the soft sensor flagged it about 60 hours before the release assay could. (Simulated demonstration data.)

Read article
Reproducing a Published CHO Perfusion Model in Invert Assist
ProductJune 10, 2026

Reproducing a Published CHO Perfusion Model in Invert Assist

We rebuilt Richelle et al.'s 2022 CHO cell-culture intensification model in Invert Assist, turning a published paper into an executable, interactive report. The central question: could parameters fit on small-scale fed-batch data reproduce the paper's perfusion design without re-estimating the model? They could — and the reproduction surfaced a units mismatch, showed the bleed controller absorbs most parameter uncertainty, and pinpointed direct lysed-cell measurement as the highest-value next experiment.

Read article
Bioraptor vs. Invert vs. Genedata: Best Bioprocess AI Platform for Scale-Up & Pharma Manufacturing
ProductDecember 2, 2025

Bioraptor vs. Invert vs. Genedata: Best Bioprocess AI Platform for Scale-Up & Pharma Manufacturing

Compare Bioraptor, Invert, and Genedata to see which bioprocess AI platform delivers the fastest scale-up, real-time insights, and AI-ready data for pharma and bioprocessing teams. Understand why experts choose Invert for USP, DSP, and manufacturing.

Read article